Home Akorn Reaffirms 2015 Revenue and EPS Guidance
 

Keywords :   


Akorn Reaffirms 2015 Revenue and EPS Guidance

2015-03-10 16:40:35| Biotech - Topix.net

Akorn, Inc. reaffirms its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million and adjusted diluted earnings per share of between $1.88 and $1.98. Akorn's Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 10:15 a.m. EDT at the Loews Miami Beach Hotel in Miami Beach, Florida.

Tags: revenue guidance eps reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »